Search

Lincoln Lana Krochmal

from Los Gatos, CA
Age ~77

Lincoln Krochmal Phones & Addresses

  • 15891 Shannon Rd, Los Gatos, CA 95032 (408) 356-3221
  • 49 Planters Row, Skillman, NJ 08558 (609) 466-2719 (908) 466-2719
  • East Amherst, NY
  • New Hope, PA
  • Campbell, CA

Public records

Vehicle Records

Lincoln Krochmal

View page
Address:
15891 Shannon Rd, Los Gatos, CA 95032
VIN:
4JGBB86E57A178586
Make:
MERCEDES-BENZ
Model:
M-CLASS
Year:
2007

Resumes

Resumes

Lincoln Krochmal Photo 1

President And Chief Executive Officer

View page
Location:
Berkeley, CA
Industry:
Pharmaceuticals
Work:
Excaliard Pharmaceuticals
President and Chief Executive Officer
Skills:
Sustainability
Lincoln Krochmal Photo 2

Lincoln Krochmal

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Lincoln Krochmal
Director
QUINNOVA PHARMACEUTICALS, INC
Manufacturing Pharmaceutical Preparations · Mfg Pharmaceutical Preparations · Druggists' Goods Merchant Whols
2500 York Rd SUITE 200, Jamison, PA 18929
411 S State St 3, Newtown, PA 18940
440 Us Hwy 22, Bridgewater, NJ 08807
301 S State St, Upper Makefield, PA 18940
(215) 860-6263, (215) 860-6265

Publications

Us Patents

Method Of Treating Keloids Or Hypertrophic Scars Using Antisense Compounds Targeting Connective Tissue Growth Factor (Ctgf)

View page
US Patent:
20120238937, Sep 20, 2012
Filed:
Feb 2, 2012
Appl. No.:
13/364547
Inventors:
Nicholas M. Dean - Encinitas CA, US
Lincoln Krochmal - Los Gatos CA, US
Gregory Hardee - Del Mar CA, US
J. Gordon Foulkes - Encinitas CA, US
Niall O'Donnell - Encinitas CA, US
Leroy Young - Wildwood MO, US
Mark Jewell - Eugene OR, US
International Classification:
A61K 31/7088
A61K 31/713
A61K 31/7105
A61K 31/711
A61M 5/00
A61K 31/712
A61K 31/7115
A61M 37/00
A61N 1/30
A61P 17/02
A61K 31/7125
US Classification:
604 20, 514 44 A, 604 22, 604506
Abstract:
This invention provides methods of preventing formation of, or treating, fibrotic lesions, including skin scars such as keloids and hypertrophic scars which comprise administering to the subject by one or more injection a compound which comprises a modified oligonucleotide, such as a modified antisense oligonucleotide, siRNA, or oligodeoxyribonucleotide, which inhibits expression of protein involved in fibrosis. Dosing of the antisense using an intradermal threading technique is also described.

Acne Gel

View page
US Patent:
20060222712, Oct 5, 2006
Filed:
Feb 17, 2006
Appl. No.:
11/356516
Inventors:
Lincoln Krochmal - Los Gatos CA, US
Alex Yaroshinsky - Mountain View CA, US
Assignee:
Connetics Corporation - Palo Alto CA
International Classification:
A61K 31/7034
A61K 31/203
A61K 9/14
US Classification:
424486000, 514035000, 514559000
Abstract:
This combination of clindamycin (1%) and tretinoin (0.025%), solubilized in a hydrogel, resulted in significantly greater improvements in acne vulgaris (reduced lesion counts and ISGA) than either drug alone or vehicle and effectively treated both non-inflammatory and inflammatory lesions with a convenient, once-daily application.

Method Of Treating Keloids Or Hypertrophic Scars Using Antisense Compounds Targeting Connective Tissue Growth Factor (Ctgf)

View page
US Patent:
20200190521, Jun 18, 2020
Filed:
Sep 20, 2019
Appl. No.:
16/136750
Inventors:
Nicholas M. Dean - Encinitas CA, US
Lincoln Krochmal - Los Gatos CA, US
Gregory Hardee - Del Mar CA, US
J. Gordon Foulkes - Encinitas CA, US
Niall O'Donnell - St. Louis MO, US
Leroy Young - Wildwood MO, US
Mark Jewell - Eugene OR, US
Assignee:
Excaliard Pharmaceuticals, Inc. - New York NY
International Classification:
C12N 15/113
A61K 45/06
A61K 31/712
A61K 31/7088
Abstract:
This invention provides methods of preventing formation of, or treating, fibrotic lesions, including skin scars such as keloids and hypertrophic scars which comprise administering to the subject by one or more injection a compound which comprises a modified oligonucleotide, such as a modified antisense oligonucleotide, siRNA, or oligodeoxyribonucleotide, which inhibits expression of protein involved in fibrosis. Dosing of the antisense using an intradermal threading technique is also described.

Method Of Treating Keloids Or Hypertrophic Scars Using Antisense Compounds Targeting Connective Tissue Growth Factor (Ctgf)

View page
US Patent:
20170022501, Jan 26, 2017
Filed:
Sep 25, 2015
Appl. No.:
14/865652
Inventors:
- New York NY, US
Lincoln Krochmal - Los Gatos CA, US
Gregory Hardee - Del Mar CA, US
J. Gordon Foulkes - Encinitas CA, US
Niall O'Donnell - St. Louis MO, US
Leroy Young - Wildwood MO, US
Mark Jewell - Eugene OR, US
Assignee:
EXCALIARD PHARMACEUTICALS, INC. - New York NY
International Classification:
C12N 15/113
Abstract:
This invention provides methods of preventing formation of, or treating, fibrotic lesions, including skin scars such as keloids and hypertrophic scars which comprise administering to the subject by one or more injection a compound which comprises a modified oligonucleotide, such as a modified antisense oligonucleotide, siRNA, or oligodeoxyribonucleotide, which inhibits expression of protein involved in fibrosis. Dosing of the antisense using an intradermal threading technique is also described.
Lincoln Lana Krochmal from Los Gatos, CA, age ~77 Get Report